76 related articles for article (PubMed ID: 32522926)
1. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders.
Okatani T; Nishimura MF; Egusa Y; Yoshida S; Nishimura Y; Nishikori A; Yoshino T; Yamamoto H; Sato Y
J Clin Exp Hematop; 2024 Mar; 64(1):1-9. PubMed ID: 38281745
[TBL] [Abstract][Full Text] [Related]
3. Unusual manifestation of methotrexate-associated lymphoproliferative disorder as a palatal mass.
Watanabe T; Teratani Y
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36175042
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis.
Kato H; Suzuki M; Misumi K; Kohsaka H
Immunol Med; 2023 Dec; 46(4):191-195. PubMed ID: 37199221
[TBL] [Abstract][Full Text] [Related]
5. Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.
In A; Stopa BM; Cuoco JA; Stump MS; Apfel LS; Rogers CM
World Neurosurg; 2023 Nov; 179():118-126. PubMed ID: 37574195
[TBL] [Abstract][Full Text] [Related]
6. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders.
Kurisu N; Hiyama T; Harada Y; Fukushima N; Katsuya N; Ureshino H; Ichinohe T; Kiuchi Y
Ocul Immunol Inflamm; 2022 Nov; ():1-6. PubMed ID: 36395469
[TBL] [Abstract][Full Text] [Related]
7. Regression of Necrotic Lesions after Methotrexate Withdrawal in Patients with Methotrexate-Associated Lymphoproliferative Disorders: A Retrospective CT Study.
Kitayama T; Tanaka T; Kanie Y; Marukawa Y; Kojima K; Tanaka T; Takao S; Hiraki T
Acta Med Okayama; 2024 Feb; 78(1):29-36. PubMed ID: 38419312
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.
Miyamoto Y; Kawasoe C; Ito K; Oguri N; Murashima T; Kamibeppu T; Nagai T; Takamori H; Kamimura T; Mukai S; Sato Y; Kamoto T
J Med Case Rep; 2023 Dec; 17(1):524. PubMed ID: 38129899
[TBL] [Abstract][Full Text] [Related]
9. A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma.
Ueda Y; Tanaka T; Asakura S; Yano T
J Clin Exp Hematop; 2023 Sep; 63(3):177-180. PubMed ID: 37518272
[TBL] [Abstract][Full Text] [Related]
10. A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis.
Nagata Y; Akiba S; Horiuchi H; Okumoto K; Hachinohe S; Ohe R
Clin J Gastroenterol; 2024 Apr; ():. PubMed ID: 38642276
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate‑related other iatrogenic immunodeficiency‑associated lymphoproliferative disorder in the CNS and medication‑related osteonecrosis of the jaw occurring simultaneously: A case report.
Kato T; Mizumoto C; Inoue F; Watanabe T; Yamanaka S; Fukuhara S; Nakao K
Exp Ther Med; 2024 Jan; 27(1):41. PubMed ID: 38125353
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
Masuda Y; Imura K; Sano Y; Yagi H
J Dermatol; 2024 Feb; 51(2):e53-e54. PubMed ID: 37752863
[No Abstract] [Full Text] [Related]
13. Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature.
Uneda A; Hirashita K; Kanda T; Yunoki M; Yoshino K; Kurozumi K; Date I
NMC Case Rep J; 2020 Jul; 7(3):121-127. PubMed ID: 32695560
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia.
Zhang Y; Qiu Y; Wang Z; Wang R; Jin R; Hinkle LE; Wu X
Front Pharmacol; 2020; 11():839. PubMed ID: 32625086
[TBL] [Abstract][Full Text] [Related]
15. Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders.
Ichikawa S; Goshima S
Jpn J Radiol; 2024 Mar; 42(3):235-245. PubMed ID: 37926781
[TBL] [Abstract][Full Text] [Related]
16. Primary Hepatic Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders After Methotrexate Therapy.
Hatayama Y; Sugiyama H; Murakami D; Oura H; Shima Y; Shirato M; Nishino T; Nakazawa T; Suehiro K; Arai M
J Med Cases; 2023 Aug; 14(8):282-288. PubMed ID: 37692367
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature.
Afonso C; Roque A; Almeida C; Pimentão MB; Julião MJ; Silva R; Geraldes C; Gomes M
Case Rep Hematol; 2022; 2022():7178065. PubMed ID: 35535243
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-associated Lymphoproliferative Disorder in the Liver Resembling Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Tsuruoka M; Inoue J; Kakazu E; Ninomiya M; Iwata T; Sano A; Masamune A
Intern Med; 2020 Sep; 59(18):2255-2260. PubMed ID: 32522926
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
